These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 27904861)

  • 41. Updates in the management of hepatocellular carcinoma.
    Wong R; Frenette C
    Gastroenterol Hepatol (N Y); 2011 Jan; 7(1):16-24. PubMed ID: 21346848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous therapies of hepatocellular carcinoma-an update.
    Chapiro J; Geschwind JF
    Chin Clin Oncol; 2013 Dec; 2(4):36. PubMed ID: 25841915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver-directed therapy for hepatocellular carcinoma.
    O'Leary C; Mahler M; Soulen MC
    Chin Clin Oncol; 2021 Feb; 10(1):8. PubMed ID: 32527111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?
    Seinstra BA; van Delden OM; van Erpecum KJ; van Hillegersberg R; Mali WP; van den Bosch MA
    Insights Imaging; 2010 Jul; 1(3):167-81. PubMed ID: 23100194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current locoregional therapies and treatment strategies in hepatocellular carcinoma.
    Cardarelli-Leite L; Hadjivassiliou A; Klass D; Chung J; Ho SGF; Lim HJ; Kim PTW; Mujoomdar A; Liu DM
    Curr Oncol; 2020 Nov; 27(Suppl 3):S144-S151. PubMed ID: 33343208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thermal ablation of hepatocellular carcinoma.
    Crocetti L; Lencioni R
    Cancer Imaging; 2008 Feb; 8(1):19-26. PubMed ID: 18331969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current status of radiofrequency ablation of hepatocellular carcinoma.
    Rhim H; Lim HK; Choi D
    World J Gastrointest Surg; 2010 Apr; 2(4):128-36. PubMed ID: 21160861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic options for intermediate-advanced hepatocellular carcinoma.
    Zhang ZM; Guo JX; Zhang ZC; Jiang N; Zhang ZY; Pan LJ
    World J Gastroenterol; 2011 Apr; 17(13):1685-9. PubMed ID: 21483627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loco-regional treatment of hepatocellular carcinoma.
    Lencioni R
    Hepatology; 2010 Aug; 52(2):762-73. PubMed ID: 20564355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.
    Ghavimi S; Apfel T; Azimi H; Persaud A; Pyrsopoulos NT
    J Clin Transl Hepatol; 2020 Jun; 8(2):168-176. PubMed ID: 32832397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on Embolization Therapies for Hepatocellular Carcinoma.
    Kishore S; Friedman T; Madoff DC
    Curr Oncol Rep; 2017 Jun; 19(6):40. PubMed ID: 28421483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ablative strategies for recurrent hepatocellular carcinoma.
    Wang L; Liu BX; Long HY
    World J Hepatol; 2023 Apr; 15(4):515-524. PubMed ID: 37206650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent Advances in Tumor Ablation for Hepatocellular Carcinoma.
    Kang TW; Rhim H
    Liver Cancer; 2015 Sep; 4(3):176-87. PubMed ID: 26674766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Locoregional Therapies of Cholangiocarcinoma.
    Sommer CM; Kauczor HU; Pereira PL
    Visc Med; 2016 Dec; 32(6):414-420. PubMed ID: 28229076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma.
    Lencioni R; Della Pina C; Bartolozzi C
    Abdom Imaging; 2005; 30(4):401-8. PubMed ID: 16132439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.